Thrombotic thrombocytopenic purpura screening: Difference between revisions
| Line 15: | Line 15: | ||
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3]. | According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3]. | ||
==Screening== | ==Screening== | ||
There is no insufficient evidence to recommend routine screening for TTP. | There is no insufficient evidence to recommend routine screening for TTP.<ref name="JolyCoppo2017" /> | ||
First test to be | First test to be screening for ADAMTS13 activity.<ref name="JolyCoppo2017">{{cite journal|last1=Joly|first1=Bérangère S.|last2=Coppo|first2=Paul|last3=Veyradier|first3=Agnès|title=Thrombotic thrombocytopenic purpura|journal=Blood|volume=129|issue=21|year=2017|pages=2836–2846|issn=0006-4971|doi=10.1182/blood-2016-10-709857}}</ref>ADAMTS13 activity < 10%, TTP diagnosis is confirmed. | ||
In sever deficiency of ADAMTS13 second screening is detection of anti-ADAMTS13 IgG | |||
Gene sequencing of ''DAMTS13'' is a third test is used. | |||
==References== | ==References== | ||
Revision as of 20:17, 13 September 2018
|
Xyz Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Thrombotic thrombocytopenic purpura screening On the Web |
|
American Roentgen Ray Society Images of Thrombotic thrombocytopenic purpura screening |
|
Risk calculators and risk factors for Thrombotic thrombocytopenic purpura screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
There is insufficient evidence to recommend routine screening for [disease/malignancy].
OR
According to the [guideline name], screening for [disease name] is not recommended.
OR
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].
Screening
There is no insufficient evidence to recommend routine screening for TTP.[1]
First test to be screening for ADAMTS13 activity.[1]ADAMTS13 activity < 10%, TTP diagnosis is confirmed.
In sever deficiency of ADAMTS13 second screening is detection of anti-ADAMTS13 IgG
Gene sequencing of DAMTS13 is a third test is used.